Key Insights

Highlights

Treatment Research

2 treatments under study, led by Dotarem 05 Mmolml Solución Inyectable En Vial

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
SYFfb85acc402c04f7d8064420546d82b51Phase 3Recruiting

Improving Heart Scans in Children: A Study Comparing Two Contrast Agents for MRI

Showing all 1 trials

Research Network

Common Treatments

  • Dotarem 05 Mmolml Solución Inyectable En Vial1
  • Gadopiclenol1

Active Sponsors

  • Fundacio Sant Joan De Deu1

Activity Timeline